Anzeige
Mehr »
Login
Montag, 06.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Cannabisaktien sollten nun den S&P um 60% outperformen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
18 Leser
Artikel bewerten:
(0)

Law Office of Brodsky & Smith, LLC Notifies Biolase, Inc. Investors of Upcoming October 22, 2013 Deadline in Putative Class Action Lawsuit - BIOL

BALA CYNWYD, Pa., Oct. 14, 2013 /PRNewswire/ --Law Office of Brodsky & Smith, LLC announces that a class action lawsuit has been filed in the United States District Court for the Central District of California on behalf of all those investors who purchased or otherwise acquired shares of Biolase, Inc. (Nasdaq: BIOL) ("Biolase" or the "Company") between January 7, 2013 and August 12, 2013, inclusive (the "Class Period").

Click here to learn more http://brodsky-smith.com/659-biol-biolase-inc.html, or call: 877-534-2590. There is no cost or obligation to you.

The Complaint alleges that the defendants failed to disclose that the Company was facing near term solvency and liquidity issues resulting from the Company's debt burden and sales not being as strong as reported. As a result, the Company's financial statements were false and misleading at all relevant times. On August 13, 2013, the Company announced that it was in violation of its bank covenants. On this news, shares of Biolase declined $1.61 per share, more than 47%, to close at $1.81 per share.

If you are a member of the class described above, you may, not later than October 22, 2013,move the Court to serve as a lead plaintiff of the class, if you so choose. If you purchased shares of Biolase stock during the Class Period and wish to discuss this action, you may e-mail or call the Law Office of Brodsky & Smith, LLC who will, without obligation or cost to you, answer your questions. Please contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at investorrelations@brodsky-smith.com, by visiting http://brodsky-smith.com/659-biol-biolase-inc.html, or calling toll free 877-LEGAL-90.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.

SOURCE Law Office of Brodsky & Smith, LLC

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2013 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.